Skip to main content
. 2023 May 25;6(5):e2315250. doi: 10.1001/jamanetworkopen.2023.15250

Table 3. Characteristics at Baseline Among 830 Patients, Stratified by Changes in Lung-RADS Scores Across 3 Screening Time Points in Experiment 2.

Characteristic Patients, No. (%)
Negative unchanged results (n = 631) Positive unchanged results (n = 26) Lung-RADS downgraded (n = 94) Lung-RADS upgraded (n = 79)
Lung-RADS scorea
1 or 2 631 (100) 0 0 79 (100)
3 or 4 0 26 (100) 94 (100) 0
Age, yb
<65 293 (46.4) 5 (19.2) 37 (39.4) 25 (31.6)
≥65 338 (53.6) 21 (80.8) 57 (60.6) 54 (68.4)
Sex
Female 250 (39.6) 10 (38.5) 33 (35.1) 36 (45.6)
Male 381 (60.4) 16 (61.5) 61 (64.9) 43 (54.4)
Race and ethnicity
Asian 56 (8.9) 2 (7.7) 10 (10.6) 5 (6.3)
Black 46 (7.3) 2 (7.7) 5 (5.3) 5 (6.3)
Hispanic or Latino 27 (4.3) 1 (3.8) 6 (6.4) 5 (6.3)
White 472 (74.8) 20 (76.9) 69 (73.4) 61 (77.2)
Otherc 16 (2.5) 0 2 (2.1) 2 (2.5)
Missing 14 (2.2) 1 (3.8) 2 (2.1) 1 (1.3)
Educational levela
Less than college 281 (44.5) 17 (65.4) 42 (44.7) 43 (54.4)
College graduate 196 (31.1) 5 (19.2) 34 (36.2) 19 (24.1)
Postgraduate 154 (24.4) 4 (15.4) 18 (19.1) 17 (21.5)
Smoking status
Current 253 (40.1) 7 (26.9) 42 (44.7) 37 (46.8)
Former 364 (57.7) 19 (73.1) 52 (55.3) 41 (51.9)
Missing 14 (2.2) 0 0 1 (1.3)
Family history of lung cancera
Yes 140 (22.2) 4 (15.4) 20 (21.3) 21 (26.6)
No 491 (77.8) 22 (84.6) 74 (78.7) 58 (73.4)
Age-adjusted CCI scorea
0 or 1 84 (13.3) 2 (7.7) 9 (9.6) 6 (7.6)
2 or 3 407 (64.5) 16 (61.5) 58 (61.7) 48 (60.8)
≥4 140 (22.2) 8 (30.8) 27 (28.7) 25 (31.6)
Primary insurance
Medicare and/or Medicaid 272 (43.1) 18 (69.2) 47 (50.0) 30 (38.0)
Private or commercial 348 (55.2) 8 (30.8) 45 (47.9) 47 (59.5)
Otherd 9 (1.4) 0 2 (2.1) 2 (2.5)
Missing 2 (0.3) 0 0 0
Distance to screening centere
≤Median 301 (47.7) 14 (53.8) 45 (47.9) 40 (50.6)
>Median 325 (51.5) 12 (46.2) 48 (51.1) 39 (49.4)
Missing 5 (0.8) 0 1 (1.1) 0
Median household incomea,f
≤Median 309 (49.0) 15 (57.7) 52 (55.3) 44 (55.7)
>Median 322 (51.0) 11 (42.3) 42 (44.7) 35 (44.3)
ADI state rankg
≤Median 362 (57.4) 14 (53.8) 40 (42.6) 44 (55.7)
>Median 231 (36.6) 11 (42.3) 50 (53.2) 31 (39.2)
Missing 38 (6.0) 1 (3.8) 4 (4.3) 4 (5.1)
Type of referring physiciana,b
Pulmonology, thoracic oncology, radiology or surgery 102 (16.2) 4 (15.4) 20 (21.3) 24 (30.4)
Otherh 529 (83.8) 22 (84.6) 74 (78.7) 55 (69.6)
Expected follow-up examination
Before COVID-19 595 (94.3) 25 (96.2) 89 (94.7) 69 (87.3)
During COVID-19 pause 8 (1.3) 0 1 (1.1) 2 (2.5)
After COVID-19 pause 28 (4.4) 1 (3.8) 4 (4.3) 8 (10.1)

Abbreviations: ADI, Area Deprivation Index; CCI, Charlson Comorbidity Index; Lung-RADS, Lung CT Screening Reporting & Data System.

a

Variable was adjusted for in experiment 2 (ie, significant baseline factors from experiment 1).

b

P < .05 from the χ2 test.

c

Subcategories were American Indian or Alaska Native, Native Hawaiian or Pacific Islander, more than 1 race, or racial and ethnic group not otherwise stated.

d

Subcategories were Veterans Health Administration, self-pay, and other insurance not specified.

e

Median distance to screening center was 5.48 miles.

f

Median household income was $74 011.

g

Median ADI state rank was 3.

h

Subcategories were family medicine, general internal medicine, and obstetrics and gynecology.